Trifarotene
RxNorm 2205637
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2205637 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: trifarotene.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
FNPrescribable
Full form of descriptor (FN):
Product containing trifarotene (medicinal product)
(Atom ID: 11826605)
INPrescribable
Ingredient (IN):
Trifarotene
(Atom ID: 11456693)
PTPrescribable
Designated preferred name (PT):
Trifarotene
(Atom ID: 11827078)
FNPrescribable
Full form of descriptor (FN):
Trifarotene (substance)
(Atom ID: 11827079)
PTPrescribable
Designated preferred name (PT):
Trifarotene-containing product
(Atom ID: 11827082)
Patient Education
Trifarotene Topical
Trifarotene is used to treat acne in adults and children 9 years of age and older. Trifarotene is in a class of medications called retinoids. It works by promoting peeling of affected skin areas, unclogging pores, and preventing new pimples from forming under the skin.
[Learn More]
* Please review the disclaimer below.